Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Rising Attendance For GI Cancer Congress Attests To Importance And Impact
The ESMO Conference: 11th World Congress on Gastrointestinal Cancer opens next week in Barcelona, Spain with a substantial increase in registered attendees over previous years, providing important practice updates and promising new research into the numerous types of cancers that affect the gastrointestinal tract. "Ongoing study and changing standards in the treatment of gastrointestinal cancers have made it mandatory for clinicians to continually update their knowledge to keep up with advances in the field," says Congress co-chair Dr. Eric Van Cutsem. "The World Congress on Gastrointestinal Cancer addresses the immediate practice implications of these changes."

Shreveport, La., Center Continues To Provide HIV/AIDS Services After 20 Years
The Shreveport Times profiled the 20-year-old Shreveport, La.-based Philadelphia Center, an agency that provides HIV/AIDS services to "an average of nearly 600 people each year in northwest Louisiana" and provides "about 1,400 free HIV tests each year." The organization also has a residential program called the Mercy Center, "a haven for homeless people with HIV or those fighting addiction and other challenges," according to the Times. The center in large part is supported by an annual auction from which proceeds "help the agency operate support groups, coordinate medical, dental and housing services for clients, provide food and medicine to people and offer free, on-the-spot HIV testing," the article states. The center recently opened a satellite office in a nearby town in response to an increase in HIV infections in the area (Brumble 8/2).
News of the day
DFG Presents 2009 MAK And BAT Values List
The Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area established by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has issued the MAK and BAT Values List for 2009. This year"s list contains 62 changes and new entries.
Mental Health

Apthera Receives Special Protocol Assessment (SPA) From FDA For Pivotal Phase III Trial Of NeuVax In Early-Stage Breast Cancer

Apthera, Inc. announced that it reached an agreement with the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) for its planned Phase III clinical trial of the Company"s lead drug, NeuVax. The SPA is a written agreement between the trial"s sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of the Phase III trial to be used in support of a Biologics License Application (BLA). The SPA approval letter was received from the FDA on June 19, 2009, concluding a 21-month reiterative process between Apthera, the breast oncology community in the U.S. and the Agency. Chief Medical Officer, William E. Gannon, M.D., said, "We would like to thank FDA reviewers for their input and guidance during the SPA approval process and are pleased that the Agency has indicated an agreement to proceed with the Phase III protocol." The multicenter, double-blind, randomized pivotal trial is expected to enroll 700 women diagnosed with HER2/neu-expressing tumors and who have completed standard of care consisting of surgery, chemotherapy and radiotherapy. Women must have a common HLA haplotype (HLA-A2 or -A3) and must agree to be followed for 5-10 years. The primary endpoint of the study is disease-free survival (DFS) as determined by disease recurrence or death from any cause, and the first analysis of the data will occur after 70 recurrence events or approximately 3 years from the start of the study. Alton C. Morgan, Ph.D., President and CEO, added, "The positive outcome of the SPA process means Apthera has reached a major developmental milestone for NeuVax. With regulatory approval of the design of the pivotal trial, this achievement has created a value inflection milestone for both the product and the Company." Apthera

Cosmetic Surgery Abroad commented:

Well I think nothing gives better information on breast cancer topic rather than this article. Nice post. Keep it up

10.05.2012


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009